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Highlights: 
 We looked at the peripheral lymphocyte phenotypes in dog with babesiosis. 
 The % of T lymphocytes were reduced in infected dogs versus controls. 
 The % T helper lymphocytes was lower in complicated versus uncomplicated 
dogs. 
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ABSTRACT 
Immunity to Babesia infection requires both innate and acquired responses, 
including cell mediated- and humoral responses.  The aims of this study were to 
investigate the variation in selected peripheral blood lymphocyte phenotypes in dogs 
with virulent babesiosis at presentation and over time after treatment, and to 
determine whether these were correlated with the severity of clinical signs.  Forty-
four dogs naturally infected with B. rossi were studied and 5 healthy dogs were 
included as controls.  Blood samples were collected from the jugular vein at 
admission, prior to any treatment, and at 24 hours and 48 – 72 hours.  Leukocytes 
were incubated with canine specific, fluorochrome conjugated anti-CD3, anti-CD4, 
anti-CD8, and anti-B cell markers. Babesia-infected dogs were divided into 
complicated or uncomplicated groups on clinical grounds and in-house laboratory 
assays.  The percentage CD3+ lymphocytes in the complicated group was lower 
compared to the controls (P = 0.014) and uncomplicated group (P = 0.007). The 
percentage CD4+ T lymphocytes in the complicated group was lower compared to 
the controls (P = 0.027) and uncomplicated group (P = 0.014).  Both the complicated 
as well as the uncomplicated groups expressed a lower percentage CD8+ T 
lymphocytes compared to the control group (P<0.001 and P = 0.005, respectively).  
The percentage B lymphocytes was higher in the complicated group at 48 - 72 
hours.  These findings could indicate the presence of a functional immune 
suppression secondary to increased apoptosis or redistribution of effector 
lymphocytes and/or a combination of other immune modulatory mechanisms induced 
by B. rossi infection.   
Keywords: babesiosis, canine, flow cytometry, lymphocyte, immunology 
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1. Introduction 
Babesiosis is the second most important hemoparasite in mammals (Schnittger et 
al., 2012), has a global distribution, causes significant animal morbidity and mortality, 
is an emerging zoonosis, and is the most important blood transfusion acquired 
disease in humans in the USA (Herwaldt et al., 2011; Krause et al., 2003).  The dog 
parasite, Babesia rossi, is an intra-erythrocytic tick borne protozoan parasite that 
occurs predominantly in southern Africa (Schoeman, 2009). Of the six Babesia 
parasite species that infect dogs, it is the most virulent (Schoeman, 2009).  The 
infection results in a peracute as well as an acute disease and it is one of the most 
prevalent diseases in domestic dogs in South Africa, where it results in high 
morbidity and mortality (Collett, 2000).  The severity of the disease has been 
reported to depend on the age and immune status of the host (Schoeman, 2009).  
Hemolytic anemia due to both intravascular and extravascular hemolyses is a 
consistent feature of the disease (Jacobson, 2006; Schoeman, 2009).  Typical 
complications include severe anemia, cerebral pathology (characterized by seizures 
in normoglycemic dogs) (Jacobson, 2006), hepatopathy and icterus, secondary 
immune-mediate hemolytic anemia (IMHA), acute respiratory distress syndrome 
(ARDS) (Jacobson and Clark, 1994), hypoglycemia (Keller et al., 2004), acute kidney 
injury (AKI) (Jacobson and Clark, 1994; Lobetti and Jacobson, 2001), 
hyperlactatemia (Jacobson and Lobetti, 2005; Leisewitz et al., 2001; Nel et al., 
2004), hemoconcentration (Jacobson and Clark, 1994; Welzl et al., 2001), 
pancreatitis (Mohr et al., 2000), and disseminated intravascular coagulation (DIC) 
(Goddard et al., 2013). 
There is evidence to suggest that, similar to malaria, the disease caused by 
Babesia spp. is the result of an exuberant host response, which may lead to 
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systemic inflammatory response syndrome, collateral organ damage and even death 
(Ahmed, 2002; Clark and Jacobson, 1998; Hemmer et al., 2000; Welzl et al., 2001; 
Wright et al., 1989).  Babesiosis and malaria share many similarities with regards to 
complex clinical signs, underlying pathophysiology and immunopathology with many 
of the disease features being attributed to the host response (Allred and Al-Khedery, 
2004; Clark, 1982; Krause et al., 2007; Maegraith et al., 1957; Wright et al., 1988). 
Both diseases are vector borne and caused by an intra-erythrocytic protozoan 
(Krause et al., 2007).  Much of the pathology associated with these diseases is 
thought to be secondary to a marked pro-inflammatory milieu resulting in organ 
failure and death (Clark and Jacobson, 1998; Goddard et al., 2016; Jacobson and 
Clark, 1994; Krause et al., 2007).  The parallels between human malaria, canine 
babesiosis, sepsis, and other systemic inflammatory states are well recognized 
(Clark et al., 2004; Jacobson and Clark, 1994; Reyers et al., 1998).  Severe systemic 
inflammation can also result in a hypo-inflammatory immune response (Bone et al., 
1997; Hotchkiss and Karl, 2003; Hotchkiss et al., 2003).  The complex interactions 
between pro- and anti-inflammatory responses have also been demonstrated in 
bovine babesiosis (Goff et al., 2001). 
Immunity to Babesia infection depends on both innate and acquired responses, 
which are both T lymphocyte- and antibody-mediated (Brown, 2001).  Resolution of 
acute B. bovis infection in immunologically naïve animals depends on a strong innate 
immune response that leads to activation of macrophages via interferon-γ (IFN-γ) 
and parasite derived products, and results in parasite elimination by phagocytosis 
and production of toxic macrophage metabolites, especially nitric oxide (Brown et al., 
2006).  Protection against clinical disease in persistently infected animals or in 
successfully immunized animals relies on activation of antigen-specific cluster of 
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differentiation (CD) 4+ T lymphocytes (helper T lymphocytes [TH]) that secrete IFN-γ 
and promote the production of neutralizing antibodies, which are critical to the 
adaptive immune response (Brown, 2001; Brown and Palmer, 1999; Goff et al., 
1998).  At present limited information on the host response to canine babesiosis is 
available. The Babesia parasite, more so after being damaged or inactivated by anti-
babesial therapy, stimulates a rapid humoral antibody response, which enhances the 
cellular immune response (Adaszek et al., 2015; Wulansari et al., 2003).  Clinical 
resolution of canine babesiosis has been suggested to be associated with the 
stimulation and intensity of the CD4+ T lymphocyte cellular immunity (Adaszek et al., 
2015).    
The first objective of this study was to investigate the variation in selected 
peripheral blood lymphocyte phenotypes at presentation in dogs naturally infected 
with B. rossi, and to determine whether this was correlated with the severity of 
clinical signs.  The second objective was to monitor the changes over time in the 
selected peripheral blood lymphocyte phenotypes after treatment.  We hypothesized 
that the percentage of selected peripheral lymphocyte phenotypes would be 
decreased in dogs with the complicated form of the disease compared to dogs with 
the uncomplicated disease form and healthy controls.    
2. Materials and methods 
This was a prospective, descriptive longitudinal study, which included client-
owned dogs, naturally infected with B. rossi that presented for veterinary care to the 
Onderstepoort Veterinary Academic Hospital, South Africa, between January 2014 
and December 2014.  The research protocol was approved by the University of 
Pretoria’s Animal Ethics Committee (V091-13; 15 January 2014).   
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Infection with Babesia parasites was diagnosed by demonstration of intra-
erythrocytic trophozoites on stained thin blood smears, and was confirmed as B. 
rossi by PCR and reverse line blot (RLB) (Matjila et al., 2008).  The control dogs 
included five healthy, client-owned blood donor dogs.  The control dogs were not 
matched for age or sex.  Owner consent was obtained for enrolment of all the dogs 
in this study. 
2. 1 Animals 
Dogs diagnosed with babesiosis were included in the study if they fulfilled a 
defined set of selection criteria.  Suitable dogs were of any breed and either sex, 
provided that they were ≥12 weeks of age, weighed ≥3 kg, and had a demonstrable 
parasitemia on a stained thin peripheral blood smear.  Dogs were excluded if they 
were co-infected with B. vogeli or Ehrlichia canis based on PCR and RLB assay 
results.  Dogs were also excluded if any signs of concurrent chronic or inflammatory 
disease conditions, any obvious infections or wounds, or any signs of trauma were 
present.  Vaccination, glucocorticoid therapy, or any unrelated metabolic illness or 
babesiosis within the four weeks prior to presentation were also reasons for 
exclusion.  Cases presenting with only mild or moderate anemia (hematocrit >12%), 
that were ambulatory and had no historical or clinical indication of significant 
concurrent organ involvement, were considered uncomplicated and were treated as 
outpatients.  Dogs were classified with complicated disease when one or more of the 
following were identified: severe anemia (hematocrit ≤12%) necessitating transfusion 
with packed red cells; acute kidney injury (oliguria/anuria and persistently elevated 
serum creatinine concentration, despite appropriate fluid therapy); cerebral 
babesiosis (neurological signs in the face of normoglycemia and that could not be 
attributed to any other cause); hepatopathy and/or icterus (elevated alanine 
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aminotransferase and alkaline phosphatase activities with/without indications of 
cholestasis such as biliruburia and/or bilirubinemia; or elevated bile acids on a 
starved sample in the absence of any signs of cholestasis); hypoglycemia (blood 
glucose <3.3 mmol/L); hyperlactatemia (blood lactate >2.5 mmol/L); secondary 
immune-mediated hemolytic anemia (positive warm in-saline agglutination or 
Coombs-positive, and/or marked spherocytosis); acute respiratory distress syndrome 
(dyspnoea, adventitious lung sounds, radiological evidence of lung consolidation or 
edema, and blood-gas evidence of ventilation-perfusion mismatch); 
hemoconcentration (hematocrit >37% in association with intravascular hemolysis, 
low total protein, with concurrent clinical collapse); pancreatitis (elevated serum 
lipase activity, or a  positive SNAP test for canine-specific pancreatic lipase (cPLI; 
IDEXX Laboratories) associated with abdominal pain, vomiting, ultrasonographic 
evidence of acute pancreatitis); and disseminated intravascular coagulation 
(thrombocytopenia with concurrent prolonged prothrombin and activated partial 
thromboplastin time, increased D-dimer and fibrin/fibrinogen degradation products 
concentrations, and decreased antithrombin activity).  
The dogs received standard care for canine babesiosis, which included 
antibabesial treatment with diminazene aceturate (Berenil® RTU 0.07 g/mL, Intervet 
Schering-Plough Animal Health SA, Isando, Johannesburg, South Africa, dosed at 
3.5 mg/kg once off), transfusion with packed red cells and intravenous fluids as 
needed.  Dogs with secondary IMHA were treated with glucocorticoids (Lenisolone® 
5mg, Aspen Pharmacare, Woodmead, Sandton, South Africa, dosed at 2 mg/kg per 
os twice a day).  Additionally, any further related complications were treated 
accordingly at the discretion of the attending clinician.  Control dogs were considered 
healthy based on history, a full clinical examination, peripheral blood smear 
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evaluation, complete blood count (CBC), as well as PCR and RLB assays to rule out 
parasitemia. 
2. 2 Sample collection 
Peripheral venous blood was collected at presentation prior to any treatment, and 
at 24 hours and 48 - 72 hours after presentation.  Blood samples were collected from 
the jugular vein from each dog with a 21-gauge needle by careful venipuncture with 
minimal stasis. The blood samples were collected into serum and EDTA Vacutainer 
plastic tubes (BD Vacutainer tubes).  The EDTA sample was used to perform a CBC, 
PCR and RLB assays, and flow cytometric evaluation. 
2. 3 Reagents and antibodies for flow cytometric analysis 
Red blood cell lysing solution (BD FACS Lysing Solution, catalog no. 349202, 
Franklin Lakes, New Jersey, USA), pH-balanced phosphate-buffered saline (BD 
CellWASH, catalog no. 349524, Franklin Lakes, New Jersey, USA) and calibration 
beads (SPHERO™ Rainbow Calibration Particles (6 and 8 Peaks), BD Biosciences, 
catalog no. 653144 and 653145, Franklin Lakes, New Jersey, USA) were used.  The 
fluorochrome-labelled monoclonal antibodies for the surface markers of canine 
lymphocytes included APC-conjugated anti-Dog Pan T cell (Clone LSM 8.358; 
isotype mIgM) as the marker for T-lymphocytes; PE-conjugated anti-Dog CD4 (Clone 
LSM 12.125; isotype mIgG1) as the marker for CD4+ T lymphocytes; FITC-
conjugated anti-Dog CD8 (Clone LSM 1.140; isotype mIgG1) as the marker for CD8+ 
T lymphocytes (Canine T Lymphocyte Cocktail, BD Biosciences, material number 
558699, Franklin Lakes, New Jersey, USA); and PE-conjugated anti-B Cell marker 
(Clone LSM 11.425; isotype mIgG1) as the marker for B lymphocytes (Canine 
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Activated T Lymphocyte Cocktail, BD Biosciences, material number 558704, Franklin 
Lakes, New Jersey, USA) (Cobbold and Metcalfe, 1994).  
2. 4 Sample preparation and staining method for identification of lymphocyte 
phenotypes 
Based upon the peripheral lymphocyte count, a calculated volume of EDTA-
anticoagulated whole blood, containing 106 lymphocytes, was centrifuged at 1520 g 
for 10 minutes at room temperature within one hour after blood collection to separate 
peripheral blood leukocytes (PBLs) from whole blood.  This step ensured that 
enough leukocytes could be harvested, as well as effective lysis of the red blood 
cells in the sample tubes, as large volumes of blood were often required to obtain 
~106 lymphocytes, because of peripheral leukopenia.  The plasma was removed and 
2 mL of BD FACS lysing solution was added to the cellular pellet and left for 15 
minutes at room temperature to lyse all red blood cells after resuspending the 
cellular pellet.  Thereafter the solution was centrifuged at 450 g for 20 minutes at 4˚C 
to concentrate the PBLs into a pellet, and the supernatant was removed with a 
pipette and sterile plastic tip.  The pelleted PBLs were then resuspended and 
washed twice by the addition of 2 mL of cooled staining buffer (BD CellWASH) 
followed by centrifugation at 450 g for 20 minutes at 4˚C.  PBLs, containing 106 
lymphocytes, were then resuspended in 500 μL staining buffer, from which two tubes 
with 100 μL of the suspension were prepared and stained with 4 μL (20 μL of 
antibody per 106 cells) of the primary antibody mix (canine T lymphocyte cocktail; 
canine activated T lymphocyte cocktail) for 15 minutes in the dark at 4˚C.  Once 
stained, the cells were washed once, as above, and resuspended in 500 μL staining 
buffer. 
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2. 5 Total white cell count and lymphocyte count determination and flow cytometric 
analysis 
Lymphocyte counts were determined, within 30 minutes of collection, on the 
ADVIA 2120 (Siemens, Munich, Germany) through 2-dimensional laser light 
scattering. Flow cytometric analysis was performed by the primary author, within two 
to three hours of collection, on the Accuri C6 flow cytometer (BD Biosciences, 
Franklin Lakes, New Jersey, USA) interfaced with a computer and analysed using 
BD CSampler Software (BD Biosciences, Franklin Lakes, New Jersey, USA).  The 
instrument was calibrated for sample acquisition using SPHERO™ Rainbow 
Calibration Particles (6 Peaks and 8 Peaks).  Compensation was performed on all 
dual labelled samples to ensure adequate separation of events. 
Unstained cells were used to define the lymphocyte population, based on their 
forward-angle and side-angle light scatter characteristics (Fig. 1a).  Cells in the 
unstained lymphocyte gate were used to formulate the next plot and subsequently, 
the lymphocytes were gated based on their CD3 (APC), CD4 (PE), CD8 (FITC) or B 
cell marker (PE) expression (Fig. 1b – d).  Cells that were dual positive for both CD3 
and CD4 as well as CD3 and CD8 were defined as CD4+ T lymphocytes and CD8+ T 
lymphocytes, respectively.  A minimum of 5000 lymphocytes were acquired for the 
initial gated population.  Results were expressed as the percentage cells of the 
different phenotypes (T lymphocytes, CD4+ T lymphocytes, CD8+ T lymphocytes, 
and B lymphocytes) within the lymphocyte population.  
2. 6 DNA extraction and PCR 
DNA was extracted from 200 μL EDTA-anticoagulated whole blood using a blood 
and tissue extraction kit (QIAmp blood and tissue extraction kit, Qiagen, Venlo, The 
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Netherlands) according to the manufacturer’s instructions.  Molecular diagnosis of B. 
rossi and exclusion of other Babesia, Theileria, Ehrlichia and Anaplasma spp. were 
performed using PCR and RLB.  PCR was conducted with a set of primers that 
amplified a 460-540 base pair fragment of the 18S SSU rRNA spanning the V4 
region, a region conserved for Babesia and Theileria.  The Ehrlichia PCR amplified 
the V1 hypervariable region of the 16S SSU rRNA.  The membrane used for RLB 
included probes for B vogeli, B. rossi, B. canis, and E. canis (Matjila et al., 2008). 
2. 7 Statistical analysis 
The normality assumption was evaluated using the Shapiro-Wilk test and the total 
leukocyte and lymphocyte counts were log-transformed to approximate normality for 
between-group analysis.  Age and weight were compared between the groups 
(complicated, uncomplicated and control) using analysis of variance (ANOVA) and 
gender proportions were compared using the Fisher’s exact test.  One-way ANOVA 
was used to assess differences between groups at presentation; if significant 
differences were present, the Bonferroni multiple comparison test was used as post 
hoc analysis.   Differences between groups (complicated and uncomplicated) in the 
lymphocyte phenotypes over time was evaluated using linear mixed models with 
animal as random effect and time as the repeated measure, while adjusting for 
glucocorticoid therapy and packed red cell transfusion and applying the Bonferroni 
correction.  Statistical analyses were performed using commercial software 
packages (SPSS Statistics 23.0 (IBM Corporation, Armonk, NY, U.S.A), Stata 12.1 
(StataCorp, College Station, TX, U.S.A.) and NCSS 2007 (NCSS, Kaysville, UT, 
U.S.A.)); P ≤ 0.05 was considered significant. 
3. Results 
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3. 1 Study population 
Of the 48 dogs naturally infected with Babesia that were sampled, 44 dogs 
infected with B. rossi were included in the study: two dogs were co-infected with 
parvovirus, one dog was co-infected with E. canis, and one dog was only infected 
with B. vogeli.  Twenty-two Babesia-infected dogs were included in each of the 
complicated and uncomplicated disease groups.  Complications included: severe 
anemia (n = 11); AKI (n = 1); cerebral babesiosis (n = 1); hepatopathy and/or icterus 
(n = 11); hypoglycemia (n = 5); hyperlactatemia (n = 10); concurrent hypoglycemia 
and hyperlactatemia (n = 4); secondary IMHA (n = 8); ARDS (n = 2), and 
hemoconcentration (n = 2).    The mean age (range) and weight (range) of the dogs 
in the complicated disease group were 26 months (3 - 91) and 16.5 kg (3.4 - 45.6), 
respectively, and included 17 male and five female dogs.  The breeds included 
consisted of mixed breed (n = 8), Jack Russell terrier (n = 6), German shepherd dog 
(n = 3), Boerboel (n = 2), and one of each of the following, Siberian husky, chow 
chow, smooth-haired fox terrier, and American pit bull terrier.  The mean age (range) 
and weight (range) of the dogs in the uncomplicated disease group were 27 months 
(4 - 84) and 13 kg (3.0 - 32), respectively, and included 12 male and 10 female dogs.  
The breeds included consisted of mixed breed (n = 8), Jack Russell terrier (n = 4), 
Labrador retriever (n = 3), and one of each of the following; basset hound, smooth-
haired dachshund, wire-haired fox terrier, rottweiler, Yorkshire terrier, and 
cockerspaniel.  
Five control dogs were sampled.  The control dogs included two males and three 
females, with a mean age (range) and weight (range) of 52 months (24 - 76) and 
28.2 kg (20.0 - 35.0), respectively.  The breeds included German shepherd dog (n = 
14 
 
2), and one each of the following: standard French poodle, golden retriever, and a 
mixed breed.  
The weight of the healthy control dogs was significantly higher (P = 0.011) 
compared to the uncomplicated disease group.  There were no significant 
differences in age or gender between the three groups.  
3. 2 Comparison of total leukocyte count, lymphocyte count and associated flow 
cytometric variables between groups at presentation.   
Table 1 contains a summary of the variables for the groups at presentation.  
Results for 22 dogs in both the complicated and uncomplicated disease groups were 
available.  There were no significant differences between groups in the mean total 
leukocyte count; however, compared to the controls, the mean lymphocyte count 
was significantly lower in both the complicated and uncomplicated disease groups (P 
= 0.008 and P = 0.003, respectively).  The mean CD3+ lymphocytes percentage in 
the complicated disease group was significantly lower compared to the controls (P = 
0.014) and uncomplicated disease group (P = 0.007) (Fig. 2a). Similarly, the mean 
CD4+ T lymphocytes percentage in the complicated disease group was significantly 
lower compared to the controls (P = 0.027) and uncomplicated disease group (P = 
0.014) (Fig. 2b).  Both the complicated and uncomplicated disease groups 
expressed a significantly lower mean CD8+ T lymphocytes percentage compared to 
the control group (P< 0.001 and P = 0.005, respectively) (Fig. 2c); however, there 
was no significant difference between the two disease groups.  There were no 
significant differences between the groups in the mean B lymphocytes percentage.  
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3. 3 Change over time in total leukocyte count, lymphocyte count, and lymphocyte 
phenotypes, and differences between groups at, 24 and 48 - 72 hours post-
presentation 
Table 2 contains a summary of the variables for the complicated and 
uncomplicated disease groups at 24 hours as well as 48 - 72 hours post-
presentation. Results of 18 dogs in both the complicated and uncomplicated disease 
groups were available for the 24 hour post-presentation period, and results of 13 
dogs in both the complicated and uncomplicated disease groups were available for 
the 48 - 72 hours post-presentation period.  The mean total leukocyte count was 
significantly increased at 24 hours and 48 - 72 hours compared to the values at 
presentation for the complicated (P = 0.016 and P = 0.002, respectively) and 
uncomplicated (P < 0.001 for both) disease groups.  Similarly, the mean lymphocyte 
count was significantly increased at 24 hours and 48 - 72 hours compared to the 
values at presentation for the complicated (P < 0.001 for both) and uncomplicated (P 
< 0.001 for both) disease groups.  Treatment with packed red blood cells or daily 
glucocorticoids post-presentation did not have any significant effect on the total 
leukocyte or lymphocyte counts.   
Evaluation of the mean CD3+ T lymphocyte phenotype percentages for the 
complicated and uncomplicated disease groups at 24 hours and 48 - 72 hours 
revealed no significant difference between groups or over time.  The mean CD4+ T 
lymphocyte percentage was significantly decreased in the uncomplicated disease 
group at 48 - 72 hours (P = 0.019). The mean CD8+ T lymphocyte percentage was 
significantly increased in the uncomplicated disease group at 24 hours (P = 0.047).  
In addition, the mean CD8+ T lymphocyte percentage was significantly higher in the 
uncomplicated disease group compared to the complicated disease group at 24 
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hours (P = 0.014) (Fig. 2d).  The mean B lymphocyte percentage was significantly 
increased in the complicated disease group at 48 - 72 hours (P = 0.041).  Treatment 
with packed red blood cells had no effect on any of the lymphocyte phenotype 
variables; however, dogs treated with daily glucocorticoids post-presentation had a 
significantly higher percentage of B lymphocytes (P = 0.020) at the time points post-
presentation.  
4. Discussion 
This is the first report of a reduced percentage of T lymphocytes (CD3+), 
specifically CD4+ and CD8+ T lymphocytes, in the peripheral blood of dogs infected 
with B. rossi.  In addition, the study also showed that the percentage of T 
lymphocytes in dogs with the complicated form of the disease was significantly lower 
compared to dogs with the uncomplicated form of babesiosis.  A significant reduction 
in the percentage of the TH lymphocytes (CD3
+ CD4+) was evident in the complicated 
Babesia-infected dogs compared to both the healthy control dogs and uncomplicated 
Babesia-infected dogs.  Although other studies have reported on similar decreases 
in the percentage and number of T lymphocytes and TH lymphocytes in peripheral 
blood of dogs naturally infected with B. canis (Adaszek et al., 2015) and 
experimentally infected with B. gibsoni (Wulansari et al., 2003), the host immune 
response to Babesia infection has not been extensively studied.  The reduced 
percentage of T lymphocytes, especially TH (CD4
+) lymphocytes, at presentation in 
dogs infected with B. rossi may be indicative of a functional immunosuppression.  
Similarly, the lymphoproliferative response in dogs naturally infected with B. gibsoni, 
in particular those with subclinical infections or relapse infection, revealed 
depression of lymphocyte blastogenesis (Adachi et al., 1993). 
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In malaria, T lymphocytes dictate the magnitude of the parasite load entering the 
erythrocytic cycle by directly controlling the growth and development of the pre-
erythrocytic Plasmodium stages, as well as the pathogenesis of the infection by 
directing the immune response elicited by the erythrocytic stage (Spence and 
Langhorne, 2012).  Moreover, during the erythrocytic life cycle stages, CD4+ T 
lymphocytes also contribute to parasite elimination through cytokine secretion, 
macrophage activation and the direction of humoral immunity (Pombo et al., 2002; 
Spence and Langhorne, 2012).  In the erythrocytic life cycle stages it is assumed 
that humoral immune responses play a key role in host response (Langhorne et al., 
2008).  In murine models B lymphocytes and antibodies are critical in eliminating 
parasites and also play a regulatory role in CD4+ T lymphocyte subset responses 
(Langhorne et al., 1998).   
A reduction in the percentage of CD4+ T lymphocytes was noted in the 
uncomplicated Babesia-infected dogs at 48 - 72 hours post-presentation compared 
to the percentage at presentation.  In contrast, the percentage of CD4+ T 
lymphocytes was not significantly different at either time point post-infection 
compared to the percentage at presentation in the complicated Babesia-infected 
dogs.  These findings differ from a recent study that showed an increased 
percentage of CD4+ T lymphocytes after treatment with imidocarb in dogs naturally 
infected with B. canis (Adaszek et al., 2015).  However, that study did not 
differentiate between complicated and uncomplicated cases. Moreover, the infected 
dogs in our study were treated with diminazene aceturate, a minor-groove-binding 
agent that acts preferentially at the level of the mitochondrial DNA, thus influencing 
cell proliferation, ultrastructure, and mitochondrial activity of the targeted parasite 
(Shapiro and Englund, 1990). In addition to its anti-parasitic effect, it has been 
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shown that diminazene aceturate administration during infection also modulates the 
host immune response by diminishing T lymphocyte and macrophage 
hyperactivation, lowering the percentage expression of FoxP3 regulatory T 
lymphocytes, as well as lowering the systemic pro-inflammatory cytokine 
concentrations (Kuriakose et al., 2012).  We suggest that, in our population of dogs, 
the combination of infection with B. rossi (which reduces the proportion of TH 
lymphocytes), together with the reported immunosuppressive effect of diminazene 
aceturate, resulted in host immunosuppression. B. canis and B. gibsoni are also less 
virulent parasites and hence may not have the same effect on the immune system as 
B. rossi.  
In our study the percentage of CD8+ T lymphocytes was significantly reduced in 
both the complicated and uncomplicated Babesia-infected dogs compared to the 
healthy control dogs at presentation.  Previous studies have reported that CD8+ T 
lymphocytes do not seem to play a role in parasite clearance during the acute phase 
of Babesia spp. infections (Igarashi et al., 1999; Shimada et al., 1996).  In murine 
malaria models CD8+ T lymphocytes producing IFN-γ are crucial for host protection 
during the pre-erythrocytic life cycle stage (Schofield et al., 1987).  In mice infected 
with P. yoelii, lower numbers of effector CD8+ T lymphocytes were found to be 
mainly due to increased apoptosis rather than reduced recruitment or proliferation 
rates of naïve T lymphocytes (White et al., 2015).  Similar mechanisms resulting in 
slower expansion kinetics of antigen-specific CD8+ T lymphocytes may be involved 
in B.rossi-infected dogs.  Furthermore, unlike malarial parasites, Babesia spp. do not 
have a tissue stage in the mammalian host which may also account for the lack of 
requirement of CD8+ T lymphocytes in the immune response against the early phase 
of the infection (Brown, 2001). 
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The percentage of CD8+ T lymphocytes was significantly higher in the 
uncomplicated Babesia-infected dogs at 24 hours post-presentation.  Similar findings 
have been reported in dogs infected with B. canis and B. gibsoni (Adaszek et al., 
2015; Wulansari et al., 2003).  In Babesia infections the central role of CD4+ T 
lymphocytes is to aid in cell mediated immunity, including the proliferation of CD8+ T 
lymphocytes, activation of macrophages, or the production of cytokines, as well as 
the humoral immune response (Preston and Jongejan, 1999).  Therefore, the 
reduced percentage of CD8+ T lymphocytes at 24 hours post-presentation in the 
complicated Babesia-infected dogs compared to uncomplicated Babesia-infected 
dogs may be as a result of the significantly reduced proportion of CD4+ T 
lymphocytes in the complicated Babesia-infected dogs at presentation. 
Compared to the uncomplicated group, the complicated Babesia-infected dogs 
had a significantly reduced percentage of circulating T lymphocytes, in particular TH 
lymphocytes.  Dogs with complicated disease have a reported mortality rate of 10%, 
with 80% dying within the first 24 hours of hospital admission (Keller et al., 2004; Nel 
et al., 2004) (Schoeman et al., 2007).  Increased concentrations of pro-inflammatory 
cytokines, in particular interleukin-6 and monocyte-chemotactic protein-1 (Goddard 
et al., 2016), and a high parasitemia (Bohm et al., 2006) have been associated with 
increased mortality.  The lower proportion of circulating lymphocyte subtypes in the 
complicated disease group in our study suggests a specific profile of inflammatory 
and modulatory cytokines, potentially related to a higher parasite burden, resulting in 
a unique host immune response in this particular group of Babesia-infected dogs. 
No significant differences were noted at presentation in the percentage of B 
lymphocytes in the Babesia-infected dogs and the healthy control dogs. This is 
similar to what has been reported in dogs infected with B. canis (Adaszek et al., 
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2015).  This is not an unexpected finding since it is doubtful that antibody-dependent 
mechanisms of immunity play a role in the first few rounds of parasite multiplication 
within an infection. However, it has been shown that antibody mediated 
neutralization does play a role in the short period between the tick bite and 
erythrocyte invasion during which time the Babesia parasite is extracellular and 
exposed (Abdalla et al., 1978; Salama et al., 2013).  Contrary to the group of dogs 
infected with B. canis, where the percentage of CD21+ B lymphocytes remained 
unchanged throughout the entire study period (Adaszek et al., 2015), the percentage 
of B lymphocytes in our study increased at 48 - 72 hours post-presentation in the 
complicated Babesia-infected group.  In dogs infected with B. gibsoni, the CD21+ B 
lymphocytes in treated animals showed the first significant increase 14 days after 
infection, which corresponded to 7 days after initiation of clindamycin therapy 
(Wulansari et al., 2003).  The findings of an upregulation of T helper response, 
accompanied by an IgG response, in mice infected with B. microti (Chen et al., 
2000), suggest that, similar to malaria, antibody responses are crucial for controlling 
parasitemia after the acute infection is resolved (Fell and Smith, 1998; Taylor-
Robinson, 1995).  Therefore, the increased percentage B lymphocytes in the 
Babesia-infected dogs may be representative of a later TH2 aided B-cell-dependant 
type response.  
In general, the effects of glucocorticoids on lymphocytes are variable and 
dependent on the glucocorticoid dose, as well as on the lymphoid subpopulation and 
activation state (Ammersbach et al., 2006).  A significant decrease in the number of 
circulating B lymphocytes in dogs treated daily for 14 days with prednisone has been 
reported (Rinkardt et al., 1999).  In addition, immunosuppressive dosages of 
prednisone given to dogs for three consecutive days resulted in marked decreases in 
21 
 
the percentage of lymph node CD21+ B lymphocytes at day 1, 3 and 38 after 
initiation of therapy (Ammersbach et al., 2006).  In our study we observed that 
Babesia-infected dogs that received glucocorticoids showed a significantly higher 
percentage circulating B lymphocytes at the time points post-presentation compared 
to Babesia-infected dogs that did not received glucocorticoid therapy.  The subset of 
dogs that did receive glucocorticoid therapy in our study were all classified as having 
secondary IMHA as a complication (n = 8).  It therefore appears that the increase in 
the percentage of B lymphocytes noted in the dogs that received glucocorticoid 
therapy, may be attributed directly to increased antibody production in IMHA, or it 
may be as a result of variation in the B lymphocyte response to glucocorticoids in 
infected dogs with an associated secondary IMHA.  It may also represent a delayed 
effect of glucocorticoids on the B lymphocyte population.  Interestingly, no 
statistically significant effect of glucocorticoid therapy was noted on the T 
lymphocytes in our study.  This is in contrast to a reported decrease in circulating 
CD4+ and CD8+ T lymphocytes in healthy dogs receiving prednisone at a daily 
dosage of 2 mg/kg for 14 days (Rinkardt et al., 1999).  Prednisone has been 
reported to induce in vitro apoptosis of peripheral T lymphocytes in a time- and dose-
dependent fashion (Lanza et al., 1996).  The lack of a glucocorticoid effect noted on 
the T lymphocytes and subsets in our study may reflect either a delayed effect of 
glucocorticoids, or that the dosage used was not adequate to induce a decrease in 
the circulating T lymphocytes. 
Although the mean blood lymphocyte count for both uncomplicated and 
complicated Babesia-infected dogs was within the laboratory reference interval (1 – 
4.8 x109/L) throughout the study, similar to a previous study of dogs infected with B. 
rossi (Scheepers et al., 2011), it was significantly lower in the group of infected dogs 
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compared to the healthy control dogs.  The lymphocyte count also increased 
significantly at 24 hours and 48 – 72 hours post-presentation in both the complicated 
and uncomplicated disease groups compared to values at presentation.  Lymphocyte 
migration and retention in several organs, especially the spleen and liver, have been 
demonstrated during peak parasitemia in murine P. chabaudi infections 
(Kumararatne et al., 1987; Playfair and de Souza, 1982).  Furthermore, the observed 
peripheral leukocytosis (primarily due to a lymphocytosis) two to five days after peak 
parasitemia in murine malaria was determined to be due to a redistribution of the 
lymphocyte pool (Kumararatne et al., 1987). Redistribution of splenic cells is central 
to the acute immune response of naïve animals to hemoparasitic infection and 
remarkable similarities of this acute splenic response have been demonstrated in 
both B. bovis-infected calves (Schneider et al., 2011) as well as P. chabaudi-infected 
mice (Leisewitz et al., 2004).  Investigation of the lymphocyte trafficking patterns in 
canine babesiosis might provide valuable insights into the protective role of the 
spleen against babesiosis.     
Limitations to this study included its clinical nature which prohibited 
standardization of the time period of infection prior to presentation; dogs were 
therefore at different stages of infection when presented, which could have 
influenced the results.  Another limitation is the lack of specific isotype controls to 
define fluorescence gates for the control population and to detect the presence of 
non-specific staining.  Furthermore, antibody saturation curves were not performed 
to determine the optimal concentration to use for each sample; nonetheless, the 
concentration of lymphocytes in each sample was known which allowed the 
calculation of an appropriate volume of antibody based on the manufacturer’s 
recommendation.     
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5. Conclusions 
This study has demonstrated a significantly reduced percentage of both CD4+ 
and CD8+ T lymphocytes in the peripheral blood of dogs naturally infected with B. 
rossi, particular in the dogs with the complicated form of the disease.  These findings 
are consistent with the presence of a functional immune suppression secondary to 
increased apoptosis or redistribution of effector T lymphocytes and/or a combination 
of other immune modulatory mechanisms caused by B. rossi infection.  Our results 
suggest that additional studies are required to further elucidate the immune response 
caused by B. rossi-infection, particularly in the spleen. A hypo-inflammatory immune 
response might be just as detrimental as an excessive systemic inflammatory 
response. A better understanding of the canine host immune response to Babesia 
infection may aid in vaccine development as well as immunotherapeutic approaches 
tailored to the individual immune status, resulting in appropriate regulation of the 
immune response which might be the key to improved outcomes in these dogs.   
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Figure legends 
Fig. 1 Flow cytometric analysis of peripheral lymphocyte phenotypes. (a) The 
lymphocyte population was identified and gated based on forward-angle and side-
angle light scatter characteristics of unstained cells.  (b – d) Subsequently the 
lymphocytes were gated on their CD3 (in APC) (b), B cell marker (in PE) (b), CD4 (in 
PE) (c), or CD8 (in FITC) (d) expression.  Values in the quadrant indicate the 
percentage of cells. 
Fig. 2 Box plots of the CD3+ lymphocyte (a), CD4+ T lymphocyte (b), and CD8+ T 
lymphocyte (c) percentages in the healthy control group of dogs and the Babesia-
infected dogs with uncomplicated and complicated disease at admission, and the 24 
hours post-presentation CD8+ lymphocyte percentages in the Babesia-infected dogs 
with uncomplicated and complicated disease (d).  The box represents the 
interquartile range (IQR), the line represents the median, the upper and lower 
whiskers represent values within 1.5×IQR of the 75th and 25th percentiles 
respectively; outliers are plotted as open circles and asterisks represent extreme 
outlier values that are 3 times removed from the IQR.  
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Table 1 Hematologic and lymphocyte phenotype data in healthy control dogs and in 
dogs with complicated and uncomplicated babesiosis at presentation.  
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Variable 
Controls  (n = 5) 
Babesia-infected           
(n = 44) 
Complicated Babesia-
infected      
(n = 22) 
Uncomplicated 
Babesia-infected           
(n = 22) 
Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  
Total white cell count (x109/L) 10.08 ± 2.70 9.32 ± 15.20 12.46 ± 21.06 6.18 ± 2.98 
Lymphocyte count (x109/L) 2.71 ± 1.07 a,b,c 1.33 ± 0.80 a 1.41 ± 1.0 b 1.27 ± 0.61 c 
CD3+ lymphocytes (%) 65.24 ± 15.33 b 43.64 ± 24.70 32.96 ± 23.04 b,d 54.32 ± 21.90 d 
CD3+/4+ lymphocytes (%) 40.56 ± 15.38 b 26.76 ± 16.57 19.91 ± 15.37 b,d 33.61 ± 15.10 d 
CD3+/8+ lymphocytes (%) 21.62 ± 17.27 a,b,c 8.10 ± 5.40 a 6.25 ± 5.58 b 9.95 ± 4.64 c 
B-cell lymphocytes (%) 9.22 ± 4.00 6.16 ± 5.10 4.88 ± 3.28 7.44 ± 6.19 
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a Significant difference between control and Babesia-infected group (P < 0.05) 
b Significant difference between control and complicated Babesia-infected group (P < 
0.05) 
c Significant difference between control and uncomplicated Babesia-infected group (P < 
0.05) 
d Significant difference between complicated Babesia-infected group and uncomplicated 
Babesia-infected group (P < 0.05) 
 
 
 
 
 
 
 
 
Table 2 Hematologic and lymphocyte phenotype data in dogs with complicated and 
uncomplicated babesiosis at 24 hours and 48 - 72 hours post-presentation.  
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Variable 
24 hours 48 - 72 hours 
Complicated  
(n = 18) 
Uncomplicated  
(n = 18) 
Complicated  
   (n = 13) 
Uncomplicated  
(n = 13) 
Mean ± SD  Mean ± SD  Mean ± SD  Mean ± SD  
Total white cell count (x109/L) 15.68 ± 12.11 a 12.09 ± 5.63 c 19.94 ± 9.27 b 18.25 ± 10.20 d 
Lymphocyte count (x109/L) 2.35 ± 1.20 a 3.53 ± 1.88 c 3.33 ± 1.43 b 4.63 ± 3.61d 
CD3+ lymphocytes (%) 40.44 ± 16.96 50.31 ± 17.63 45.57 ± 12.52 42.88 ± 19.02 
CD3+/4+ lymphocytes (%) 24.98 ± 11.07 30.12 ± 12.26 26.51 ± 9.22 25.11 ± 9.49 d 
CD3+/8+ lymphocytes (%) 8.12 ± 6.06 e 13.02 ± 7.28 c,e 8.18 ± 3.64 12 ± 7.71 
B-cell lymphocytes (%) 6.64 ± 7.12 6.57 ± 5.46 12.64 ± 9.70 b 9.90 ± 6.40 
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a Significant difference between complicated Babesia-infected group at presentation 
and 24 hours post-presentation (P < 0.05) 
b Significant difference between complicated Babesia-infected group at presentation 
and 48 - 72 hours post-presentation (P < 0.05) 
c Significant difference between uncomplicated Babesia-infected group at presentation 
and 24 hours post-presentation (P < 0.05) 
d Significant difference between uncomplicated Babesia-infected group at presentation 
and 48 - 72 hours post-presentation (P < 0.05) 
e Significant difference between complicated Babesia-infected group and uncomplicated 
Babesia-infected group at specified time point (P < 0.05) 
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Fig. 1 Flow cytometric analysis of peripheral lymphocyte phenotypes. (a) The lymphocyte 
population was identified and gated based on forward-angle and side-angle light scatter 
characteristics of unstained cells.  (b – d) Subsequently the lymphocytes were gated on their CD3 
(APC) (b), B cell marker (PE) (b), CD4 (PE) (c), or CD8 (FITC) (d) expression.  Values in the 
quadrant indicate the percentage of cells. 
(a) (b) 
(c) (d) 
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(a) (b) 
(c) (d) 
Fig. 2 Box plots of the CD3
+
 lymphocyte (a), CD4
+
 T lymphocyte (b),and CD8
+
 T lymphocyte (c) percentages in the healthy 
control group of dogs and the Babesia-infected dogs with uncomplicated and complicated disease at admission, and the 24 
hours post-presentation CD8
+
 lymphocyte percentages in the Babesia-infected dogs with uncomplicated and complicated 
disease (d). The box represents the interquartile range (IQR), the line represents the median, the upper and lower whiskers 
represent values within 1.5×IQR of the 75
th
 and 25
th
 percentiles respectively; outliers are plotted as open circles and asterisks 
represent extreme outlier values that are 3 times removed from the IQR.  
